Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data

Kim Boesen; Luis Carlos Saiz; Peter C Gøtzsche; Juan Erviti

doi:10.1161/CIRCOUTCOMES.124.011321

Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data

Kim Boesen^*, Luis Carlos Saiz, Peter C Gøtzsche, Juan Erviti

^*Corresponding author af dette arbejde

Copenhagen Trial Unit Rigshospitalet

Originalsprog	Engelsk
Artikelnummer	e011321
Tidsskrift	Circulation. Cardiovascular quality and outcomes
Vol/bind	18
Udgave nummer	3
Antal sider	3
ISSN	1941-7713
DOI	https://doi.org/10.1161/CIRCOUTCOMES.124.011321
Status	Udgivet - mar. 2025

Adgang til dokumentet

10.1161/CIRCOUTCOMES.124.011321

Andre filer og links

Link to publication in Scopus

Citationsformater

Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data. / Boesen, Kim; Saiz, Luis Carlos; Gøtzsche, Peter C et al.
I: Circulation. Cardiovascular quality and outcomes, Bind 18, Nr. 3, e011321, 03.2025.

Publikation: Bidrag til tidsskrift › Letter › peer review

@article{588323830cfd420baeb422d367a16b29,

title = "Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data",

keywords = "anticoagulants, atrial fibrillation, international normalized ratio, United States Food and Drug Administration, warfarin",

author = "Kim Boesen and Saiz, {Luis Carlos} and G{\o}tzsche, {Peter C} and Juan Erviti",

year = "2025",

month = mar,

doi = "10.1161/CIRCOUTCOMES.124.011321",

language = "English",

volume = "18",

journal = "Circulation. Cardiovascular quality and outcomes",

issn = "1941-7713",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range

T2 - An Analysis of US Food and Drug Administration Regulatory Data

AU - Boesen, Kim

AU - Saiz, Luis Carlos

AU - Gøtzsche, Peter C

AU - Erviti, Juan

PY - 2025/3

Y1 - 2025/3

KW - anticoagulants

KW - atrial fibrillation

KW - international normalized ratio

KW - United States Food and Drug Administration

KW - warfarin

UR - http://www.scopus.com/inward/record.url?scp=85217497751&partnerID=8YFLogxK

U2 - 10.1161/CIRCOUTCOMES.124.011321

DO - 10.1161/CIRCOUTCOMES.124.011321

M3 - Letter

C2 - 39907009

SN - 1941-7713

VL - 18

JO - Circulation. Cardiovascular quality and outcomes

JF - Circulation. Cardiovascular quality and outcomes

IS - 3

M1 - e011321

ER -